Release Date: June 30, 2025
Expiration Date: June 30, 2026
Activity Overview
Preliminary results from the recent CATALYST study found hypercortisolism in 24% of patients with type 2 diabetes who are screened for the condition. Given the high prevalence of hidden hypercortisolism among patients with type 2 diabetes, early identification and treatment of these patients may help improve outcomes.
This SimulatEd™ program is an online, on-demand activity designed to enhance clinical reasoning for health care providers involved in the diagnosis and management of hypercortisolism in patients with type 2 diabetes mellitus. It consists of a simulated patient encounter that requires learners to make clinical decisions and review updates from expert faculty on best practices in the diagnosis and management of hypercortisolism, fostering critical thinking and decision-making skills in a risk-free setting.
Target Audience
This educational activity is directed toward endocrinologists and diabetes specialists. Other HCPs involved in the care of patients with Cushing syndrome, such as NPs, PAs, RNs, will also find it useful.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Outline the role of hypercortisolism in the development of type 2 diabetes
- Describe risk factors for hypercortisolism in patients with type 2 diabetes
- Apply screening recommendations to identify hypercortisolism in patients with type 2 diabetes
- Analyze clinical trial data for therapies for hypercortisolism
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here